A 12-week, randomized, double-blinded, placebo-controlled, phase 2b study of safety, tolerability and efficacy of ar882 in gout patients
ANNALS OF THE RHEUMATIC DISEASES（2023）
Key words
Gout,Randomized control trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined